Submit Deal

DAY ONE BIOPHARMACEUTICALS

HQ - Brisbane, CA

Summary

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 311 M

Avg. Deal Size£ 156 M

Market Context

Senior Management

Jeremy Bender
CEO
Laura Cooper
Head of Communication

Sort

1ab

pr advisors (1)

1 Shared Deal

1 For

£ 94 M

Total Value

td cowen

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 217 M

Total Value

wilmerhale

HQ - Boston, United States

legal advisors (1)

1 Shared Deal

1 Opposite

£ 217 M

Total Value

white & case

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 Opposite

£ 217 M

Total Value

gordon dyal & co

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 217 M

Total Value

fenwick & west

HQ - Silicon Valley

legal advisors (1)

1 Shared Deal

1 For

£ 217 M

Total Value

lifesci partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 217 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy